MRNA CIK: 1682852

Moderna, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
16.1
FY22:
13.4
FY23:
10.3
FY24:
8.10
FY25:
6.54
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.60
FY22:
12.4
FY23:
8.10
FY24:
6.04
FY25:
5.79
Total assets
Change from FY21 to FY25
billions USD
FY21:
24.7
FY22:
25.9
FY23:
18.4
FY24:
14.1
FY25:
12.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
9.13
FY22:
4.92
FY23:
3.02
FY24:
2.21
FY25:
1.99
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.40
FY22:
1.81
FY23:
1.56
FY24:
1.04
FY25:
1.70
(positive)
Change from FY21 to FY25
billions USD
FY21:
14.1
FY22:
19.1
FY23:
13.9
FY24:
10.9
FY25:
8.65
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
24.7
FY22:
25.9
FY23:
18.4
FY24:
14.1
FY25:
12.3

All amounts in billions USD Data source:SEC EDGAR